BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33635266)

  • 1. The High-Sensitivity C-Reactive Protein to Prealbumin Ratio Predicts Adverse Cardiovascular Events after ST-Elevation Myocardial Infarction.
    Ren H; Zhao L; Liu Y; Tan Z; Luo G; Deng X
    Heart Surg Forum; 2021 Feb; 24(1):E153-E157. PubMed ID: 33635266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
    J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
    Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
    Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
    Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
    Tian C; Song J; He D; Wu J; Sun Z; Sun Z
    Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kacprzak M; Zielinska M
    Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction.
    Deng XN; Wang XY; Yu HY; Chen SM; Xu XY; Huai W; Liu GH; Ma QB; Zhang YY; Dart AM; Du XJ; Gao W
    Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):208-219. PubMed ID: 29726987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
    Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study.
    Isik T; Kurt M; Tanboga IH; Ayhan E; Gunaydin ZY; Kaya A; Uyarel H
    Cardiol J; 2016; 23(3):281-8. PubMed ID: 26711461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Zahler D; Rozenfeld KL; Stein M; Milwidsky A; Berliner S; Banai S; Arbel Y; Shacham Y
    J Nephrol; 2019 Jun; 32(3):437-443. PubMed ID: 30706372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
    Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of fractalkine/CX3CL1 concentration in patients with acute myocardial infarction treated with primary percutaneous coronary intervention.
    Xu B; Qian Y; Zhao Y; Fang Z; Tang K; Zhou N; Li D; Wang J
    Cytokine; 2019 Jan; 113():365-370. PubMed ID: 30352758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
    Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Yang L; Dong H; Lu H; Liao Y; Zhang H; Xu L; Tan Y; Cao S; Tan J; Fu S
    Medicine (Baltimore); 2019 Mar; 98(12):e14920. PubMed ID: 30896649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
    Adatia K; Farag MF; Gue YX; Srinivasan M; Gorog DA
    Thromb Haemost; 2019 Nov; 119(11):1785-1794. PubMed ID: 31437861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Variation of Troponin and Prognosis of Acute Myocardial Infarction before and after Primary Percutaneous Coronary Intervention.
    Zhao X; Wang Y; Liu C; Zhou P; Sheng Z; Li J; Zhou J; Chen R; Chen Y; Zhao H; Yan H
    J Interv Cardiol; 2020; 2020():4793178. PubMed ID: 32774185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating the erythrocyte sedimentation rate for enhanced accuracy of the global registry of acute coronary event score in patients with ST-segment elevated myocardial infarction: A retrospective cohort study.
    Li C; Wang Y; Zhang Q; Wang L; Li K; Yang X
    Medicine (Baltimore); 2020 Oct; 99(41):e22523. PubMed ID: 33031294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.